Sign in
4

Changes in Ownership

SAB Biotherapeutics, Inc. Filed Acc 0001209191-22-049950

Director bought 10,000 shares at $0.73 ($7,297)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
HAMILTON CHRISTINE E Director 2022-09-13 Purchase +10,000 $0.73 $7,297 4,993,090 D
Open-market purchases · 10,000 sh · avg $0.73 · $7,297
Loading xslF345X03/doc4.xml…